Originally broadcast: Tuesday 15th September 2020 at 12:30 – 14:00 BST
Duration: 90 minutes. Available to watch on demand
The latest insights and information for accelerating patient access
Understand the challenges of appraising medicines for rare diseases
Develop solutions and policies for the future
Examine the potential for the NICE methods review and proposed Innovative Medicines Fund
Who would benefit from registering to attend this webinar:
This webinar should be attended by representatives from UK, European and global pharmaceutical, biotech, life science and MedTech industries, as well as patient organisations and patient groups.
The job functions that will benefit most include:
• Heads of Market Access
• Managing Directors
• Country Managers
• Chief Executives
• Health Economists
• Medical Directors
• Commercial Directors
• Policy Officers/Executives
• Marketing Directors
• Policy Advisors
A solicitor by profession, Kate has wide experience of litigation and regulatory issues. She is currently working at patient charity NSPKU to improve access to drug treatments for people with the rare metabolic condition phenylketonuria.
Lindsay has championed and led patient groups throughout her career. Starting with St Johns Ambulance, Cheshire Young Carers, she has latterly held Chief Executive Officer positions at the Young Carers Network and Children Living with Inherited Metabolic Disorders.
Charlie has held a number of senior commercial, market access and business development roles at Global pharmaceutical companies including Pfizer, Amgen and currently is the General Manager, UK and Ireland at Amicus.
Copyright © 2021. MAP BioPharma Limited. All rights reserved.
MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
+44 (0) 1480 832360
MAP BioPharma Limited is a registered company in England and Wales. Company Registration Number 08209281
VAT Group Registration Number GB 292 8576 52